MedTrace Logo

DMD Voice: Qualitative Interviews With Patients and Caregivers

NCT06925269 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 68

Last updated 2025-04-30

No results posted yet for this study

Summary

The purpose of this study is to understand DMD functional losses or abilities and their association with independence and quality of life from the perspective of individuals with DMD and/or and their caregivers.

This is a qualitative interview study in which individuals with DMD and/or their caregivers will be asked to participate in a semi-structured, approximately 60- minute interview. Interviews will focus on functional abilities and independence. Caregivers and boys with DMD will be interviewed. This study includes no treatment nor intervention; however, some participants are being treated by a drug that is approved in the U.S. and the U.K. and under investigation in other geographies.

Conditions

  • Duchenne Muscular Dystrophy (DMD)

Sponsors & Collaborators

  • Italfarmaco S.A

    collaborator INDUSTRY

  • Red Nucleus Enterprise Solutions, LLC

    lead INDUSTRY

Principal Investigators

  • Mindy Leffler, M.Ed. · Red Nucleus Solutions

Eligibility

Min Age
10 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-03-31
Primary Completion
2025-12-31
Completion
2026-12-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06925269 on ClinicalTrials.gov